The prevalence of main driver mutations of CRC in our study was in alignment with globally published literature; however, the size of the studied cohort was limited due to the small number of patients undergoing simultaneous testing for BRAF, KRAS mutation status, as well as microsatellite stability status. Here, BRAF is linked to colorectal carcinoma.